Advanced Endoscopy During COVID-19

Al-Azhar University

Status: Completed

Conditions: COVID-19; Cholangitis, Secondary Biliary; Pancreas Cancer; Cholangiocarcinoma; SARS-CoV-2; Obstructive Jaundice

Treatments: Other: Endoscopic management according to standard of care

Study type: Observational

Funder types: Other

Identifiers

NCT04385147

Global-Endo-COVID

Details and patient eligibility

About

In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.

Full description

In this study, investigators aim to explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details.

evaluate the validity of different GI societies recommendations applied in different GI endoscopy units on the prevention of SARS-CoV-2 nosocomial transmission and the overall impact of this recommendations on the service provided by each GI unit.

Target audience:

• Physicians performing advanced gastrointestinal endoscopies in different countries.

Objectives:

• Primary objective:

  1- To explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details.

• Secondary objectives:

  1. Effect of COVID-19 precautions on procedure time, procedure success, complications and patient outcomes
  2. Effect of COVID-19 on working time and staff number

Process:

A questionnaire containing advanced endoscopy procedure details in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of advanced endoscopy practice in the studied countries.

Enrollment: 670 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients referred for ERCP or EUS during the study period

Exclusion criteria

• Patients refusing to participate in the study

Trial design

670 participants in 2 patient groups

ERCP

Description:

Patients who will have endoscopic retrograde cholangiopancreatography

Treatment:

Other: Endoscopic management according to standard of care

EUS

Description:

Patients who will have endoscopic ultrasound

Treatment:

Other: Endoscopic management according to standard of care